《盈利預喜》津上機床中國(01651.HK)料上財年純利按年升70%至6.6億人幣
津上機床中國(01651.HK)發盈喜,預料截至2022年3月31日止年度純利將達到約6.6億元人民幣,按年上升約70%,主要由於期內國內外經濟穩步恢復,機床行業延續2020年下半年度恢復和增長態勢,期內各主要機型均有良好銷售業績。
惟公司表示,下半財年境內多地限電限產,因應疫情防控而停工停產,對集團銷售造成一定影響,未來將繼續努力提高生產效率,降低成本及完善產品線,拓寬數控高精密機床用途及進一步擴大銷售網路。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.